FDA Panel Rules Celebrex Increases Heart Risks
Friday, February 18th, 2005A committee of doctors and scientists has unanimously voted that Pfizer Inc.’s biggest selling prescription arthritis drug Celebrex significantly raises the risk of heart attacks and stroke. Chairman of the panel, Alastair Wood, said four or five studies have shown significant cardiovascular hazards among COX-2 inhibitors, the class of drug Celebrex belongs to. Last September, [...]